Robert Dillman | Chief Medical Officer
AIVITA Biomedical, Inc.

Robert Dillman, Chief Medical Officer, AIVITA Biomedical, Inc.

Dr. Robert O. Dillman, M.D., is Chief Medical Officer of AIVITA Biomedical. Previously, Dr. Dillman served as Vice President of Oncology at Caladrius Biosciences, Inc. (formerly Neostem, Inc.), a leading development and manufacturing partner to the cell therapy industry. From May 2014 to January 6, 2016 he also served as Member of Caladrius’ Melanoma Scientific Advisory Board. Dr. Dillman has served as the Executive Medical Director of the Hoag Hospital Institute for Research and Education, in Newport Beach, California, a position he has held since 2011. Prior to this position he served as Executive Medical Director of the Hoag Family Cancer Institute from 2008-2011, and was Medical Director of the Hoag Cancer Center from 1989-2008. He has also served as a Clinical Professor of Medicine at the University of California, Irvine (“UCI”) since 1989. He also held the position of Assistant Director of the UCSD Cancer Center and Chief of Hematology/Oncology at the San Diego VA Medical Center, then Director of Experimental Clinical Oncology and Associate Director of the Ida M. Green Cancer Center of Scripps Clinic and Research Foundation in La Jolla, California.

Appearances:



WVIC/WAC Day 2 - Nov 30 @ 11:30

Chair’s opening remarks

WVIC/WAC Day 2 - Nov 30 @ 14:30

Personal dendritic cell vaccines for cancer and covid-19

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

lauren.sheppard@terrapinn.com

For sponsorship and exhibition opportunities:
Thomas Hall

thomas.hall@terrapinn.com